Accendra Health, Inc. ACH
Set alert
At close · Oct 30
After hours · Oct 30, 7:05 PM ET
- YTD
- -90.92%
- 1 year
- -94.88%
- Open
- 0.2299
- Prev close
- 0.233
- Mkt cap
- 19.55M
- Vol
- 1.55M
- Avg vol
- 1.87M
- EPS
- -1.44
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.23
- High
- 0.2542
- Forward P/E
- 2.40
- Beta
- 1.36
- Short ratio
- 0.00
- Inst. own
- 97.45%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 25, 2024
- 50-d avg
- 0.00
- 200-d avg
- 0.00
- 1y target
- 5.44
2Y chart
Events in this range
- Aug 12, 2025Rating: B of A Securities · Underperform → Underperform
- Aug 12, 2025Rating: Citigroup · Buy → Buy
- Aug 12, 2025Rating: Baird · Outperform → Outperform
- Aug 13, 2025Rating: UBS · Buy → Buy
- Aug 27, 2025Rating: JP Morgan · Underweight → Underweight
- Nov 3, 2025Downgrade: UBS · Buy → Neutral
Signals (78)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 6, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 5, 2026 | 3 weeks ago |
| RSI: Oversold | Sep 17, 2026 | 1 month ago |
| RSI: Oversold | Sep 8, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 27, 2026 | 2 months ago |
| RSI: Oversold | Aug 10, 2026 | 2 months ago |
| SMA: Bearish | Aug 6, 2026 | 2 months ago |
| SMA: Bullish | Aug 5, 2026 | 2 months ago |
| SMA: Bearish | Aug 4, 2026 | 2 months ago |
| SMA: Bearish | Aug 4, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 2 months ago |
| SMA: Bearish | Jul 31, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 20, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 14, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 9, 2026 | 3 months ago |
| SMA: Bullish | Jun 24, 2026 | 4 months ago |
| SMA: Bullish | Jun 24, 2026 | 4 months ago |
| SMA: Bearish | Jun 23, 2026 | 4 months ago |
| SMA: Bearish | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | Jun 18, 2026 | 4 months ago |
| SMA: Bullish | Jun 17, 2026 | 4 months ago |
| SMA: Bearish | Jun 15, 2026 | 4 months ago |
| SMA: Bearish | Jun 15, 2026 | 4 months ago |
| SMA: Bullish | Jun 12, 2026 | 4 months ago |
| SMA: Bullish | Jun 11, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 11, 2026 | 4 months ago |
| SMA: Bearish | May 18, 2026 | 5 months ago |
| SMA: Bearish | May 12, 2026 | 5 months ago |
| SMA: Bullish | May 11, 2026 | 5 months ago |
| SMA: Bearish | May 8, 2026 | 5 months ago |
| SMA: Bullish | May 7, 2026 | 5 months ago |
| MACD: Sell Signal | May 7, 2026 | 5 months ago |
| SMA: Bearish | May 6, 2026 | 5 months ago |
| SMA: Bullish | May 5, 2026 | 5 months ago |
| SMA: Bearish | Apr 29, 2026 | 6 months ago |
| SMA: Bullish | Apr 28, 2026 | 6 months ago |
| RSI: Overbought | Apr 28, 2026 | 6 months ago |
| RSI: Overbought | Apr 13, 2026 | 6 months ago |
| SMA: Bullish | Apr 1, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 31, 2026 | 7 months ago |
| SMA: Bearish | Mar 18, 2026 | 7 months ago |
| SMA: Bullish | Mar 10, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 4, 2026 | 8 months ago |
| SMA: Bearish | Feb 26, 2026 | 8 months ago |
| SMA: Bullish | Feb 19, 2026 | 8 months ago |
| MACD: Buy Signal | Jan 30, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 22, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 12, 2026 | 9 months ago |
| RSI: Oversold | Jan 5, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 2, 2026 | 10 months ago |
| MACD: Buy Signal | Nov 25, 2025 | 11 months ago |
| RSI: Oversold | Nov 3, 2025 | 12 months ago |
| MACD: Sell Signal | Oct 31, 2025 | 1 year ago |
| SMA: Bearish | Oct 30, 2025 | 1 year ago |
| SMA: Bullish | Oct 22, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 16, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 29, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 28, 2025 | 1 year ago |
| RSI: Oversold | Aug 11, 2025 | 1 year ago |
| SMA: Bearish | Jul 29, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 10, 2025 | 1 year ago |
| RSI: Overbought | Jun 30, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 25, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 23, 2025 | 1 year ago |
| SMA: Bullish | Jun 5, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 5, 2025 | 1 year ago |
| MACD: Sell Signal | May 23, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 25, 2025 | 1 year ago |
| RSI: Oversold | Apr 21, 2025 | 1 year ago |
| RSI: Oversold | Apr 10, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 3, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 2, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 27, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 27, 2025 | 1 year ago |
| SMA: Bearish | Feb 3, 2025 | 1 year ago |
| RSI: Oversold | Feb 3, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 30, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 7, 2025 | 1 year ago |
Key statistics
- Market cap
- 0
- Enterprise value
- 2.43B
- Trailing P/E
- 0.00
- Forward P/E
- 2.40
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 1.36
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -12.45%
- Revenue (TTM)
- 10.77B
- Revenue growth
- 1.50%
- Free cash flow
- 309.35M
- Total cash
- 32.84M
- Total debt
- 2.24B
- Return on equity
- -196.39%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Analyst view
Consensus: hold
- Target (low)
- 4.00
- Target (mean)
- 5.44
- Target (high)
- 7.00
- Strong buy0
- Buy1
- Hold2
- Sell0
- Strong sell2
Next earnings
Dec 25, 2024
Expected Dec 25, 2024. Consensus EPS estimate 0.22235.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Dec 25, 2024 | Sep 1, 2024 | 0.00 | — | — | — |
| Oct 1, 2024 | Jun 1, 2024 | 0.00 | — | — | — |
| Jul 2, 2024 | Mar 1, 2024 | 0.00 | — | — | — |
| Oct 25, 2023 | Sep 1, 2023 | 0.00 | 0.38 | — | — |
| Aug 22, 2023 | Jun 1, 2023 | 0.00 | 0.33 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 3, 2025 | UBS | down | Buy | Neutral |
| Aug 27, 2025 | JP Morgan | main | Underweight | Underweight |
| Aug 13, 2025 | UBS | main | Buy | Buy |
| Aug 12, 2025 | Baird | main | Outperform | Outperform |
| Aug 12, 2025 | Citigroup | main | Buy | Buy |
| Aug 12, 2025 | B of A Securities | main | Underperform | Underperform |
About Accendra Health, Inc.
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. The company operates in two segments, Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment also supplies a range of other home medical equipment; and patient care products, including ostomy, wound care, urology, and incontinence and other products and services. The company serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Accendra Health, Inc. was formerly known as Owens & Minor, Inc. and changed its name Accendra Health, Inc. in December 2025. The company was founded in 1882 and is based in Glen Allen, Virginia.
- Country
- United States
- Website
- owens-minor.com
News
- Accendra Health Receives Continued Listing Standard Notice from NYSE Regarding Market Capitalization and Stockholders' Equity; Intends to Submit Business Plan and Return to Compliance with NYSE Listing Standard
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
Your note
Sign in to keep a note on ACH — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BECK MARK A. | Director | Stock Award(Grant) | May 14, 2025 | 40,068 |
| COLISEUM CAPITAL MANAGEMENT, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Aug 13, 2025 | 0 |
| GARDNER-SMITH KENNETH | Director | Stock Award(Grant) | May 14, 2025 | 54,922 |
| HENKEL ROBERT J | Director | Stock Award(Grant) | May 14, 2025 | 77,412 |
| JOHNSON-MILLS RITA | Director | Stock Award(Grant) | May 14, 2025 | 54,125 |
| KLEMASH STEPHEN W. | Director | Stock Award(Grant) | May 14, 2025 | 59,051 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Coliseum Capital Management, Llc | 16.94% | 13,100,807 | 30.40M | Sep 29, 2025 |
| Vanguard Group Inc | 7.71% | 5,962,847 | 13.83M | Sep 29, 2025 |
| Blackrock Inc. | 7.26% | 5,613,838 | 13.02M | Sep 29, 2025 |
| Dimensional Fund Advisors LP | 4.53% | 3,507,559 | 8.14M | Sep 29, 2025 |
| Millennium Management Llc | 4.22% | 3,261,254 | 7.57M | Sep 29, 2025 |
| Charles Schwab Investment Management, Inc. | 4.15% | 3,208,915 | 7.45M | Sep 29, 2025 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.01% | 2,329,191 | 5.40M | Sep 29, 2025 |
| SCHWAB STRATEGIC TRUST-Schwab Fundamental U.S. Small Company ETF | 2.48% | 1,915,548 | 4.44M | Aug 30, 2025 |
| iShares Trust-iShares Russell 2000 ETF | 2.44% | 1,885,997 | 4.38M | Sep 29, 2025 |
| NORTHERN LIGHTS FUND TRUST II-Invenomic Fund | 1.67% | 1,293,892 | 3.00M | Oct 30, 2025 |
| PIMCO Equity Series-PIMCO RAE US Small Fund | 1.45% | 1,120,187 | 2.60M | Sep 29, 2025 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.07% | 824,626 | 1.91M | Sep 29, 2025 |